Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1832394
Disease: Deafness, Autosomal Recessive 12
Deafness, Autosomal Recessive 12
0.500 Biomarker disease CTD_human
Prelingual sensorineural hearing impairment
0.100 Biomarker disease HPO
CUI: C4316870
Disease: Abnormality of the eye
Abnormality of the eye
0.100 Biomarker phenotype HPO
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.070 AlteredExpression disease BEFREE PMCA2 mRNA levels are also a potential tool in identifying poor responders to therapy in women with Basal breast cancer. 27148852 2016
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.050 AlteredExpression disease BEFREE PMCA2 mRNA levels are also a potential tool in identifying poor responders to therapy in women with Basal breast cancer. 27148852 2016
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.010 AlteredExpression disease BEFREE PMCA2 expression is decreased in SC neurons at onset of symptoms in animal models of multiple sclerosis. 28780172 2018
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.020 GeneticVariation phenotype BEFREE PMCA 2 mutations are associated with deafness and PMCA 3 mutations are linked to cerebellar ataxias. 29155350 2018
CUI: C0339789
Disease: Congenital deafness
Congenital deafness
0.020 GeneticVariation disease BEFREE PMCA2 pump mutations and hereditary deafness. 29452611 2018
CUI: C0524662
Disease: Opiate Addiction
Opiate Addiction
0.010 Biomarker disease BEFREE ATP2B2, which is a member of the same calcium signalling pathway, has been associated previously with opioid dependence. 30003630 2018
CUI: C1832394
Disease: Deafness, Autosomal Recessive 12
Deafness, Autosomal Recessive 12
0.500 Biomarker disease GENOMICS_ENGLAND A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. 17234811 2007
CUI: C1384666
Disease: hearing impairment
hearing impairment
0.020 GeneticVariation phenotype BEFREE Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2. 30535804 2019
Sensorineural Hearing Loss (disorder)
0.010 Biomarker disease BEFREE Although other genes in this region remain candidates, we conclude that haploinsufficiency of ATP2B2 is the most likely cause of SNHL in 3p-- syndrome. 17208398 2007
CUI: C4706503
Disease: Distal monosomy 3p syndrome
Distal monosomy 3p syndrome
0.010 Biomarker disease BEFREE Although other genes in this region remain candidates, we conclude that haploinsufficiency of ATP2B2 is the most likely cause of SNHL in 3p-- syndrome. 17208398 2007
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.020 Biomarker disease BEFREE Combined SSCP and heteroduplex analysis of the human plasma membrane Ca(2+)-ATPase isoform 1 in patients with essential hypertension. 10425217 1999
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 Biomarker disease BEFREE Cutting off the PKM2-derived ATP supply to the PMCA represents a novel therapeutic strategy for the treatment of PDAC. 31819190 2020
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.050 Biomarker disease BEFREE Despite the lack of effect on global calcium responses, PMCA2 silencing augmented Bcl-2 inhibitor (ABT-263)-mediated MDA-MB-231 breast cancer cell death. 27613092 2016
CUI: C4551693
Disease: Wolfram Syndrome 1
Wolfram Syndrome 1
0.010 Biomarker disease BEFREE DNA analysis to examine single-nucleotide polymorphisms in 2 candidate modifier genes (ATP2B2 and Wolfram syndrome 1 [WFS1]) is summarized in this report. 18667942 2008
CUI: C0086543
Disease: Cataract
Cataract
0.010 AlteredExpression disease BEFREE Elevated PMCA2 expression in cataractous lenses might be a compensatory mechanism to overcome higher intracellular calcium levels in cataract. 18223301 2008
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.020 Biomarker phenotype BEFREE Expression of the fast calcium extrusion protein, PMCA2, in the cerebellum is amongst the highest found throughout the central nervous system, and unsurprisingly PMCA2 knockout mice exhibit cerebellar ataxia or loss of controlled movement. 29452612 2018
CUI: C0030193
Disease: Pain
Pain
0.030 Biomarker phenotype BEFREE Female-specific molecular changes potentially account for the altered pain responses.-Khariv, V., Ni, L., Ratnayake, A., Sampath, S., Lutz, B. M., Tao, X.-X., Heary, R. F., Elkabes, S. Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception. 27702770 2017
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.070 AlteredExpression disease BEFREE Furthermore, the regulation of PMCA2 membrane localization and activity in breast cancer cells requires its interaction with the PDZ domain-containing scaffolding molecule sodium-hydrogen exchanger regulatory factor (NHERF) 1. 31087002 2019
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.050 AlteredExpression disease BEFREE Furthermore, the regulation of PMCA2 membrane localization and activity in breast cancer cells requires its interaction with the PDZ domain-containing scaffolding molecule sodium-hydrogen exchanger regulatory factor (NHERF) 1. 31087002 2019
blood phenylalanine measurement by Guthrie microbiologic assay
0.100 GeneticVariation phenotype GWASCAT Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. 19043545 2008
CUI: C0523465
Disease: Serum albumin measurement
Serum albumin measurement
0.100 GeneticVariation phenotype GWASDB Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. 19043545 2008
CUI: C0027404
Disease: Narcolepsy
Narcolepsy
0.100 GeneticVariation disease GWASDB Genome-wide association database developed in the Japanese Integrated Database Project. 19629137 2009